Health
Multidose Vial Presentation of Audenz, an H5N1 Influenza Vaccine, Approved – Monthly Prescribing Reference
Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant.
The Food and Drug Administration (FDA) has approved a multidose vial presentation of Audenz (influenza A
Continue Reading
-
Business23 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News24 hours agoQueensland police to be given powers to issue on-the-spot orders to domestic violence perpetrators
-
Business19 hours agoASX 200 plunges as US tariffs fall-out continues
-
Noosa News19 hours agoPolice to get on-the-spot protection powers for DV victims